Cellebrite
CLBT
148 hedge funds and large institutions have $990M invested in Cellebrite in 2024 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 60 increasing their positions, 54 reducing their positions, and 15 closing their positions.
120% more call options, than puts
Call options by funds: $832K | Put options by funds: $379K
53% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 15
18% more capital invested
Capital invested by funds: $836M → $990M (+$153M)
11% more repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 54
5% more funds holding
Funds holding: 141 → 148 (+7)
3.39% more ownership
Funds ownership: 36.96% → 40.35% (+3.4%)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$32M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$26.6M |
| 3 |
CI
Clal Insurance
Tel-Aviv,
Israel
|
+$17.7M |
| 4 |
Goldman Sachs
New York
|
+$9.05M |
| 5 |
PM
Pembroke Management
Montreal,
Quebec, Canada
|
+$8.78M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$9.83M |
| 2 |
Millennium Management
New York
|
-$7.11M |
| 3 |
IP
Isomer Partners
New York
|
-$6.2M |
| 4 |
PF
Phoenix Financial
Givatayim,
Israel
|
-$6.1M |
| 5 |
CP
CenterBook Partners
Greenwich,
Connecticut
|
-$4.97M |
CLBT Hedge Fund Activity: Q2 2024 in Review
148 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in Cellebrite (CLBT) for Q2 2024, worth a combined $990M — up 18% from $836M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new CLBT positions and 15 closed out — a net gain of 8 holders — while 60 added to existing stakes and 54 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $32M. The largest seller was Arrowstreet Capital, cutting an estimated $9.83M.
- 148 institutional investors held Cellebrite (CLBT) as of Q2 2024, up from 141 in Q1 2024.
- Funds reported $990M of Cellebrite stock for Q2 2024, up 18% quarter-over-quarter.
- 23 funds opened new Cellebrite positions in Q2 2024 and 15 closed out, a net change of +8 holders.
- The largest Cellebrite buyer in Q2 2024 was Morgan Stanley, an estimated $32M added.
- The largest Cellebrite seller in Q2 2024 was Arrowstreet Capital, an estimated $9.83M sold.
Based on aggregated 13F filings for Q2 2024.